Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,576
Sort by:

Latin America Liver Disease Treatment Market - 2024-2031

US$ 2,499.00

Latin America Liver Disease Treatment Market reached US$ 1.3 billion in 2023 and is expected to reach US$ 2.02 billion by 2031, growing with a CAGR of 5.80% during the forecast period 2026-2031. The L...

October 2024 63 pages

Middle East and Africa Liver Disease Treatment Market - 2024-2031

US$ 2,499.00

Middle East and Africa Liver Disease Treatment Market reached US$ 981.74 million in 2023 and is expected to reach US$ 1,525.63 million by 2031, growing with a CAGR of 5.80% during the forecast period...

October 2024 72 pages

Phenylephrine Hydrochloride Market - 2024-2031

US$ 3,400.00

The Phenylephrine Hydrochloride Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...

September 2024 53 pages

Botulinum Toxin Market - 2024-2031

US$ 3,400.00

Botulinum Toxin Marketis is growing with a CAGR of 7.62% during the forecast period 2026-2035. The Botulinum Toxin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...

September 2024 41 pages

Retinoblastoma Market - 2024-2031

US$ 3,400.00

Retinoblastoma Market reached US$ 970.15 million in 2023 and is expected to reach US$ 1440.28 million by 2031, growing with a CAGR of 5.20% during the forecast period 2026-2031. The Retinoblastoma Mar...

September 2024 40 pages

Excipients in Pharmaceuticals: Global Markets to 2029

US$ 4,650.00

... future of pharmaceutical excipients market is also analyzed. Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water. Based on route of administration, the pharmaceutical excipient market is segmented ...

September 2024 105 pages

Alzheimer's Drugs – A Global Market Overview

US$ 4,500.00

Alzheimer's Drugs Market Trends and Outlook Alzheimer's disease is a degenerative neurological condition that progresses over time and is the primary cause of dementia, typically impacting individuals...

September 2024 253 pages

Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029

US$ 2,970.00

The Age-Related Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029....

September 2024 336 pages

Adalimumab Market - 2024-2031

US$ 3,400.00

Adalimumab Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Adalimumab Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned re...

September 2024 36 pages

Vitamin D Therapy Market - 2024-2031

US$ 3,400.00

Vitamin D Therapy Marketis is growing with a CAGR of 12.20% during the forecast period 2026-2035. The Vitamin D Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...

September 2024 43 pages

Anticoagulation Therapy Market - 2024-2031

US$ 3,400.00

The Anticoagulation Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...

September 2024 49 pages

Tourette Syndrome Market - 2024-2031

US$ 3,400.00

Tourette Syndrome Marketis is growing with a CAGR of 10.50% during the forecast period 2026-2035. The Tourette Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...

September 2024 43 pages

Aplastic Anemia Market - 2024-2031

US$ 3,400.00

The Aplastic Anemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...

September 2024 41 pages

Europe Theranostics Market - 2024-2031

US$ 2,499.00

Europe Theranostics Market reached US$ 501.86 million in 2022 and is expected to reach US$ 1,104.22 million by 2031, growing with a CAGR of 10.60% during the forecast period 2026-2031. The Europe Ther...

September 2024 45 pages

Treatment-Resistant Depression Market - 2024-2031

US$ 3,400.00

The Treatment-Resistant Depression Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...

September 2024 56 pages

Alpha-mannosidosis Treatment Market - 2024-2031

US$ 3,400.00

The Alpha-mannosidosis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...

September 2024 54 pages

Diffuse Cutaneous Systemic Sclerosis (DcSSc) Drugs Market - 2024-2031

US$ 3,400.00

The Diffuse Cutaneous Systemic Sclerosis (DcSSc) Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and stra...

September 2024 76 pages

Iron Overload Syndrome Treatment Market - 2024-2031

US$ 3,400.00

The Iron Overload Syndrome Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...

September 2024 58 pages

Penicillin Drug Market - 2024-2031

US$ 3,400.00

Penicillin Drug Marketis is growing with a CAGR of 4.40% during the forecast period 2026-2035. The Penicillin Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...

September 2024 41 pages

Primary Hyperoxaluria Treatment Market - 2024-2031

US$ 3,400.00

Primary Hyperoxaluria Treatment Market reached US$ 168.96 million in 2023 and is expected to reach US$ 365.49 million by 2031, growing with a CAGR of 9.80% during the forecast period 2026-2031. The Pr...

September 2024 57 pages

Endometriosis Drug Market - 2024-2031

US$ 3,400.00

Endometriosis Drug Marketis is growing with a CAGR of 10.40% during the forecast period 2026-2035. The Endometriosis Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...

September 2024 44 pages

Antidepressant Drugs Market - 2024-2031

US$ 3,400.00

Antidepressant Drugs Market reached US$ 20.6 billion in 2031 and, growing with a CAGR of 5.56% during the forecast period 2031-2035. The Antidepressant Drugs Market emerges as a key focus in DataM Int...

September 2024 46 pages

Cetirizine Hydrochloride Market - 2024-2031

US$ 3,400.00

Cetirizine Hydrochloride Market reached US$ 6,797.9 million in 2023 and is expected to reach US$ 8,882.5 million by 2031, growing with a CAGR of 3.40% during the forecast period 2026-2031. The Cetiriz...

September 2024 50 pages

US Tardive Dyskinesia Treatment Market - 2024-2031

US$ 1,899.00

US Tardive Dyskinesia Treatment Market reached US$ 3061.64 million in 2023 and is expected to reach US$ 6417.43 million by 2031, growing with a CAGR of 9.80% during the forecast period 2026-2031. The...

September 2024 57 pages

North America Focal Segmental Glomerulosclerosis Drugs Market - 2024-2031

US$ 2,499.00

North America Focal Segmental Glomerulosclerosis Drugs Market reached US$ 431.38 million in 2023 and is expected to reach US$ 1400.15 million by 2031, growing with a CAGR of 17.30% during the forecast...

September 2024 80 pages

Antibody Drugs: Technologies and Global Markets

US$ 4,650.00

... growth rate (CAGR) of 6.3% from 2017 through 2022. The global antibody drugs market for autoimmune diseases reached $37.3 billion in 2016. The market ... $37.5 billion in 2017, at a CAGR of 5.1% from 2017 through 2022. The global antibody drugs market for lymphoma reached $37.3 billion in 2016. The market should ...

September 2024 156 pages

Digital Breast Tomosynthesis Market - 2024-2031

US$ 3,400.00

Digital Breast Tomosynthesis Market reached US$ 3.5 billion in 2023 and is expected to reach US$ 6.2 billion by 2031, growing with a CAGR of 7.50% during the forecast period 2026-2031. The Digital Bre...

September 2024 54 pages

Oral Cavity Cancer Market - 2024-2031

US$ 3,400.00

Oral Cavity Cancer Market reached US$ 1.92 billion in 2023 and is expected to reach US$ 2.94 billion by 2031, growing with a CAGR of 5.60% during the forecast period 2026-2031. The Oral Cavity Cancer...

September 2024 44 pages

Urological Cancer Drugs Market - 2024-2031

US$ 3,400.00

Urological Cancer Drugs Marketis is growing with a CAGR of 11.90% during the forecast period 2026-2035. The Urological Cancer Drugs Market emerges as a key focus in DataM Intelligence latest in-depth...

September 2024 49 pages

Hazardous Drug Administration Market - 2024-2031

US$ 3,400.00

Hazardous Drug Administration Market reached US$ 459.5 million in 2023 and is expected to reach US$ 1900.9 million by 2031, growing with a CAGR of 20.20% during the forecast period 2026-2031. The Haza...

September 2024 55 pages

Osteoporosis Drugs Market - 2024-2031

US$ 3,400.00

Osteoporosis Drugs Market reached US$ 14,066.4 million in 2022 and is expected to reach US$ 19,336.6 million by 2031, growing with a CAGR of 4.10% during the forecast period 2026-2031. The Osteoporosi...

September 2024 44 pages

Drug Discovery Technologies

US$ 4,650.00

... among others. Key players in the drug discovery market include Thermo Fisher Scientific, Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., ... 23 additional tables. An overview of the global markets for drug discovery technologies. Analyses of global market trends with data from 2015, 2016, and 2017, ...

September 2024 192 pages

Post Menopausal Osteoporosis Market - 2024-2031

US$ 3,400.00

Post Menopausal Osteoporosis Market reached US$ 9.9 billion in 2023 and is expected to reach US$ 15.2 billion by 2031, growing with a CAGR of 5.40% during the forecast period 2026-2031. The Post Menop...

September 2024 54 pages

Breast Feeding Devices Market - 2024-2031

US$ 3,400.00

Breast Feeding Devices Marketis is growing with a CAGR of 6.69% during the forecast period 2026-2035. The Breast Feeding Devices Market emerges as a key focus in DataM Intelligence latest in-depth ana...

September 2024 48 pages

Cough Suppressant Drugs Market - 2024-2031

US$ 3,400.00

Cough Suppressant Drugs Marketis is growing with a CAGR of 3.40% during the forecast period 2026-2035. The Cough Suppressant Drugs Market emerges as a key focus in DataM Intelligence latest in-depth a...

September 2024 49 pages

Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028

US$ 3,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028 Repo...

September 2024 240 pages

CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027

US$ 3,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027 Report Highlights:Curr...

September 2024 210 pages

G7 Spinocerebellar Ataxia Market - 2024-2031

US$ 3,400.00

G7 Spinocerebellar Ataxia Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The G7 Spinocerebellar Ataxia Market emerges as a key focus in DataM Intelligence latest in-dep...

August 2024 51 pages

Water Treatment Aerators Market - 2024-2031

US$ 3,400.00

Water Treatment Aerators Marketis is growing with a CAGR of 6.90% during the forecast period 2026-2035. The Water Treatment Aerators Market emerges as a key focus in DataM Intelligence latest in-depth...

August 2024 50 pages

Erectile Dysfunction Drugs Market - 2024-2031

US$ 3,400.00

Erectile Dysfunction Drugs Market reached US$ 3.5 billion in 2023 and is expected to reach US$ 5.0 billion by 2031, growing with a CAGR of 4.70% during the forecast period 2026-2031. The Erectile Dysf...

August 2024 52 pages

Gastroparesis Drugs Market - 2024-2031

US$ 3,400.00

Gastroparesis Drugs Marketis is growing with a CAGR of 4.90% during the forecast period 2026-2035. The Gastroparesis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...

August 2024 45 pages

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market - 2024-2031

US$ 3,400.00

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market reached US$ 1.67 billion in 2023 and is expected to reach US$ 7.64 billion by 2031, growing with a CAGR of 21.80% during the fo...

August 2024 91 pages

India, Pakistan and Cambodia HEPATITIS C VIRUS (HCV) Treatment Market - 2024-2031

US$ 2,499.00

India, Pakistan and Cambodia HEPATITIS C VIRUS (HCV) Treatment Market reached in and is expected to reach by , growing with a CAGR of 11.10% during the forecast period 2026-. The India, Pakistan and C...

August 2024 88 pages

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

US$ 4,650.00

... depth knowledge of the global pharmaceutical and biopharmaceutical contract manufacturing, research and packaging market. The contract manufacturing segment is further ... Includes: 50 data tables An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on ...

August 2024 143 pages

India, Pakistan and Cambodia Human Immunodeficiency Virus (HIV) Treatment Market - 2024-2031

US$ 2,499.00

India, Pakistan and Cambodia Human Immunodeficiency Virus (HIV) Treatment Market reached in and is expected to reach by , growing with a CAGR of 4.50% during the forecast period 2026-. The India, Paki...

August 2024 99 pages

Human Anti-rabies Vaccine Market - 2024-2031

US$ 3,400.00

Human Anti-rabies Vaccine Marketis is growing with a CAGR of 5.70% during the forecast period 2026-2035. The Human Anti-rabies Vaccine Market emerges as a key focus in DataM Intelligence latest in-dep...

August 2024 51 pages

Anti-Suicide Drugs Market - 2024-2031

US$ 3,400.00

Anti-Suicide Drugs Market reached US$ 97.2 billion in 2023 and is expected to reach US$ 136.4 billion by 2031, growing with a CAGR of 4.50% during the forecast period 2026-2031. The Anti-Suicide Drugs...

August 2024 44 pages

Primary Immunodeficiency Diseases Market - 2024-2031

US$ 3,400.00

Primary Immunodeficiency Diseases Market reached US$ 7.3 billion in 2023 and is expected to reach US$ 13.0 billion by 2031, growing with a CAGR of 7.60% during the forecast period 2026-2031. The Prima...

August 2024 59 pages

Filters

Search

Categories

154
298
486
365
93
183
385
14,886
12,075
211
1,277
220
428
344
3,983
72
1,116

Publishers

2,237
1,678
72
37
1
3,965
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,801

Price

—

Date

—

Pages

—

Offers

44
5
1